Industry News
February 24, 2012Swiss biotech Actelion grabs rights to biologic in $68.5M deal
February 24, 2012GSK steps in to back Canadian vaccine project
February 24, 2012Biotech VC climate warmer than some thought
February 24, 2012Russian biotech VC and Quintiles to join forces on pharma services startups
February 24, 2012Forest Labs notches victory en route to FDA ruling on COPD drug
February 24, 2012I'd like to add you to my professional network
February 24, 2012Chelsea Therapeutics surges on FDA panel nod for Northera
February 23, 2012$100M Russian biotech fund opens shop in Boston
February 23, 2012New Zelboraf data shows big survival boost
February 23, 2012Sanofi slams doors on Genzyme's Cambridge, U.K., outfit
February 23, 2012Vertex vows to race ahead with interferon-free combo for hep C
February 23, 2012Satori snags $15M to fuel a trial on Alzheimer's drug
February 22, 2012UPDATE: Vivus soars after experts offer surprising support for weight drug
February 22, 2012Eisai co-developing cancer drug fueled by bacteria; U.S. trials launch soon
February 22, 2012Venture backer makes $7M bet on cardio drug tech that could rival stents